The Future Of Medicine: Cell And Gene Therapies Take The Lead
Risk-taking required, partnerships essential to advance the field
BIO panel with Roche’s James Sabry, Spark’s Federico Mingozzi and Adaptive’s Harlan Robins imagines a world where cell and gene therapies are preferred over small molecules and antibodies.
